Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 4 EP applications Joachim Seemann has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 17, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13701200

AZAHETEROCYCLIC COMPOUNDS

IPC classification:
A61K 31/497, A61K 31/4965, A61K 31/4725, A61K 31/416, C07D 495/04, C07D 417/12, C07D 413/12, C07D 405/12, C07D 403/14, C07D 403/12, C07D 401/12, C07D 241/20, A61P 31/00
Applicant:
Cancer Research Technology Ltd
Applicant:
Merck Patent GmbH
Agent:
Joachim Seemann, Merck Patent GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11773238

METHOD FOR PREPARING SUBSTITUTED N-(3-AMINO-QUINOXALIN-2-YL)-SULFONAMIDES AND THEIR INTERMEDIATES N-(3-CHLORO-QUINOXALIN-2-YL)SULFONAMIDES

IPC classification:
C07D 413/12, C07D 241/22, C07D 409/12, C07D 405/14, C07D 405/12, C07D 403/12, C07D 401/12, C07D 241/44
Agent:
Joachim Seemann, Merck KGaA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13774069

2-AMINOPYRIDINE COMPOUNDS

IPC classification:
A61K 31/495, A61K 31/4725, A61K 31/4545, A61K 31/438, C07D 498/10, C07D 491/10, C07D 471/10, C07D 417/14, C07D 401/14, C07D 401/04, A61P 35/00
Applicant:
Merck Patent GmbH
Applicant:
Cancer Research Technology Ltd
Agent:
Joachim Seemann, Merck Patent GmbH
Status:
EXAMINATION IN PROGRESS
EP16779272

COMBINATION OF A PD-1 AXIS BINDING ANTAGONIST AND AN ALK INHIBITOR FOR TREATING ALK-NEGATIVE CANCER

IPC classification:
A61K 39/00, C07K 16/28, A61K 39/395, A61K 38/00
Applicant:
Pfizer Inc
Applicant:
Merck Patent GmbH
Agent:
Joachim Seemann, Merck Patent GmbH
Status:
Request for examination was made

Please Sign in to use this feature